@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-EPA-ENTACT_AGILENT001554 a mbo:MassSpectrum ;
    dcterms:creator "EPA CCTE and Agilent Technologies" ;
    dcterms:date "2023-09-19"^^xsd:date ;
    dcterms:identifier "MSBNK-EPA-ENTACT_AGILENT001554" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights " under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "N/A" ;
            mbo:collision_energy "10" ;
            mbo:instrument_type "ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "DTXSID4044664",
                "Todralazine" ;
            mbo:ch_compound_class "N/A" ;
            mbo:ch_exact_mass 2.32096e+02 ;
            rdfs:seeAlso cas:14679-73-3 ;
            schema:inChI "InChI=1S/C11H12N4O2/c1-2-17-11(16)15-14-10-9-6-4-3-5-8(9)7-12-13-10/h3-7H,2H2,1H3,(H,13,14)(H,15,16)" ;
            schema:inChIKey inchikey:WGZDBVOTUVNQFP-UHFFFAOYSA-N ;
            schema:molecularFormula "C11H12N4O2" ;
            schema:name "DTXSID4044664",
                "Todralazine" ;
            schema:smiles "CCOC(=O)NNC1=NN=CC2=CC=CC=C21" ] ;
    mbo:has_peak [ mbo:intensity 2.368215e+00 ;
            mbo:mz 8.903858e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 24 ],
        [ mbo:intensity 1.299134e+00 ;
            mbo:mz 1.320682e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 13 ],
        [ mbo:intensity 1.109065e+00 ;
            mbo:mz 1.450634e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 2.451687e+00 ;
            mbo:mz 1.590665e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 24 ],
        [ mbo:intensity 1.798962e+01 ;
            mbo:mz 1.610822e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 180 ],
        [ mbo:intensity 1.302758e+01 ;
            mbo:mz 1.870614e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 130 ],
        [ mbo:intensity 1.726708e+01 ;
            mbo:mz 2.05072e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 172 ],
        [ mbo:intensity 1e+02 ;
            mbo:mz 2.331033e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 999 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 2.331033e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 8 ;
    mbo:pk_splash "splash10-001i-0290000000-1227d04be5015b5dac51" ;
    skos:definition "Todralazine; ESI-QTOF; MS2; CE: 10; [M+H]+" .

